NSCLC Concurrent Chemotherapy and Radiation
Sort by:
ecancer
ELCC 2025 Insights: KEYNOTE-799 - Pembro + cCRT in Unresectable Locally Advanced NSCLC
FEATURING
Martin Reck
- 4 views
- April 14, 2025
Insights from ELCC 2025
ELCC 2025 Insights: Pembro + CCRT in Unresectable Locally Advanced NSCLC - Final Analysis of KEYNOTE-799
FEATURING
Sara Ramella
- 44 views
- April 9, 2025
OncoAlert
Early Stage NSCLC: Adjuvant & Neoadjuvant Chemo + IO, Adjuvant Alectinib, Osimertinib After CRT in Stage 3 Disease
FEATURING
Gilberto Lopes
- 28 views
- March 13, 2025
- 2
OncoAlert
NSCLC & SCLC Key Radiotherapy Updates From 2024
FEATURING
Henning Willers,
Katie Keane
- 25 views
- March 13, 2025
- 1
Fox Chase Cancer Center
Unresectable Stage 3 NSCLC: Patient Selection and Treatment Options
FEATURING
Charu Aggarwal
- 196 views
- January 2, 2025
- 2
UNC Lineberger Comprehensive Cancer Center
Targeted Therapies in Resected and Unresectable NSCLC
FEATURING
Shetal Patel
- 77 views
- December 3, 2024
- 1
GRACE
Case-Based Panel: Managing EGFR Exon 19 Lung Cancer and Insights From the LAURA Study
- 78 views
- November 5, 2024
Total Health
Selected Targeted Therapies in NSCLC - Advances in Thoracic Oncology
FEATURING
Jason Porter
- 30 views
- October 29, 2024
David Carbone
Multidisciplinary Panel Discussion: New Treatment Options for Surgically Resectable NSCLC
FEATURING
Brendon Stiles
- 375 views
- October 21, 2024
- 5
ecancer
ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON, REZILIENT1, LAURA, and SKIPPirr
- 398 views
- October 11, 2024
- 3
Insights from 2024 WCLC
WCLC 2024 Insights: Mitigating Chemoradiation Toxicity in LA-NSCLC
FEATURING
Dawn Owen
- 18 views
- October 1, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Management of Radiation Toxicities in The Era of Chemo-Immunotherapy
FEATURING
Percy Lee
- 101 views
- September 24, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Interstitial Lung Disease and Lung Cancer - How Should We Proceed
FEATURING
Satoshi Ikeda
- 388 views
- September 23, 2024
- 2
Insights from 2024 WCLC
WCLC 2024 Insights: PACIFIC-BRAZIL Study - Intensified Chemo-Immuno-Radiotherapy With Durvalumab for Stage III NSCLC
FEATURING
William William
- 42 views
- September 23, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: LAURA Study - Osimertinib After Definitive CRT in Unresectable Stage III EGFRm NSCLC
FEATURING
Terufumi Kato
- 101 views
- September 18, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: NSCLC
FEATURING
Rajat Thawani
- 310 views
- August 27, 2024
- 4
MI&T Congressi
Mediastinal Staging of Lung Cancer
FEATURING
Rocco Trisolini
- 531 views
- July 22, 2024
- 5
MI&T Congressi
Radiotherapy for N2 Resected NSCLC
FEATURING
Cécile Le Péchoux
- 31 views
- July 12, 2024
- 1
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
FEATURING
Bishal Gyawali
- 105 views
- July 2, 2024
- 1
ecancer
ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials
FEATURING
Luis Raez
- 69 views
- July 2, 2024
- 1
